Wed, 21st Apr 2021 11:40
NEW DELHI, April 21 (Reuters) - The Serum Institute of India
will be able to raise its monthly output of the AstraZeneca
COVID-19 vaccine to 100 million doses by July from 60-70 million
now, later than a previous timeline of end-May, its chief
executive Adar Poonawalla told CNBC-TV18.
(Reporting by Chandini Monappa and Krishna N. Das; Editing by
Andrew Heavens)
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:
INGELHEIM, Germany, April 16 (Reuters) - Boehringer Ingelheim on Tuesday overtook Bayer as Germany's largest drugmaker when the unlisted company rep...
(Alliance News) - AstraZeneca PLC on Tuesday said that its immunotherapy Imfinzi showed positive survival rate in people with advanced biliary tract c...
April 12 (Reuters) - The European Union drug regulator found no evidence that a class of diabetes and weight-loss drugs such as Novo Nordisk's hugel...
Astrazeneca (AZN)